Baars JW - Search Results

1

[Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy].

Richel DJ, Baars JW, Wijngaarden MJ, van der Schoot CE, Vlasveld LT, Rodenhuis S. Richel DJ, et al. Among authors: baars jw. Ned Tijdschr Geneeskd. 1993 Jan 30;137(5):245-50. Ned Tijdschr Geneeskd. 1993. PMID: 7679478 Dutch.

2

Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin, cyclophosphamide and thiotepa.

Rodenhuis S, Baars JW, Schornagel JH, Vlasveld LT, Mandjes I, Pinedo HM, Richel DJ. Rodenhuis S, et al. Among authors: baars jw. Ann Oncol. 1992 Dec;3(10):855-60. doi: 10.1093/oxfordjournals.annonc.a058111. Ann Oncol. 1992. PMID: 1286049 Free article. Clinical Trial.

3

High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach.

van der Wall E, Nooijen WJ, Baars JW, Holtkamp MJ, Schorangel JH, Richel DJ, Rutgers EJ, Slaper-Cortenbach IC, van der Schoot CE, Rodenhuis S. van der Wall E, et al. Among authors: baars jw. Br J Cancer. 1995 Apr;71(4):857-62. doi: 10.1038/bjc.1995.165. Br J Cancer. 1995. PMID: 7536025 Free PMC article. Clinical Trial.

4

Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation.

Dercksen MW, Rodenhuis S, Dirkson MK, Schaasberg WP, Baars JW, van der Wall E, Slaper-Cortenbach IC, Pinedo HM, Von dem Borne AE, van der Schoot CE, et al. Dercksen MW, et al. Among authors: baars jw. J Clin Oncol. 1995 Aug;13(8):1922-32. doi: 10.1200/JCO.1995.13.8.1922. J Clin Oncol. 1995. PMID: 7543561

5

Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer.

Rodenhuis S, Westermann A, Holtkamp MJ, Nooijen WJ, Baars JW, van der Wall E, Slaper-Cortenbach IC, Schornagel JH. Rodenhuis S, et al. Among authors: baars jw. J Clin Oncol. 1996 May;14(5):1473-83. doi: 10.1200/JCO.1996.14.5.1473. J Clin Oncol. 1996. PMID: 8622061 Clinical Trial.

6

Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.

van der Wall E, Rutgers EJ, Holtkamp MJ, Baars JW, Schornagel JH, Peterse JL, Beijnen JH, Rodenhuis S. van der Wall E, et al. Among authors: baars jw. Br J Cancer. 1996 May;73(9):1080-5. doi: 10.1038/bjc.1996.208. Br J Cancer. 1996. PMID: 8624267 Free PMC article. Clinical Trial.

7

Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support.

van der Lelie H, Baars JW, Rodenhuis S, van Dijk MA, de Glas-Vos CW, Thomas BL, van Oers RH, von dem Borne AE. van der Lelie H, et al. Among authors: baars jw. Cancer. 1995 Dec 1;76(11):2338-42. doi: 10.1002/1097-0142(19951201)76:11<2338::aid-cncr2820761123>3.0.co;2-p. Cancer. 1995. PMID: 8635040 Review.

8

The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis.

van der Wall E, Schaake-Koning CC, van Zandwijk N, Baars JW, Schornagel JH, Richel DJ, Rutgers EJ, Borger JH, Beijnen JH, Rodenhuis S. van der Wall E, et al. Among authors: baars jw. Eur J Cancer. 1996 Aug;32A(9):1490-7. doi: 10.1016/0959-8049(96)00129-3. Eur J Cancer. 1996. PMID: 8911107 Clinical Trial.

9

Mobilisation of blood progenitor cells with ifosfamide and etoposide (VP-16) in combination with recombinant human G-CSF (Filgrastim) in patients with malignant lymphomas or solid tumours.

Baars JW, Holtkamp MJ, Nooyen WJ, Walll EV, Te Velde A, Dalesio O, Slaper-Cortenbach IC, Schoot EV, Richel DJ, Gerritsen WR, Schornagel JH, Rodenhuis S. Baars JW, et al. Anticancer Res. 1996 Sep-Oct;16(5B):3089-95. Anticancer Res. 1996. PMID: 8920773

10

Adjustment of the interface detector (location 71) to the absolute number of mononuclear cells in the peripheral blood: no improvement of the collection efficiency of the Fenwal CS3000 plus during progenitor cell harvests.

Baars JW, Nooyen WJ, van Beers C, Holtkamp MJ, te Velde A, Daleslo O, Slaper-Cortenbach IC, van der Schoot CE, Casteleyn K. Baars JW, et al. J Clin Apher. 1997;12(2):68-73. doi: 10.1002/(sici)1098-1101(1997)12:2<68::aid-jca3>3.0.co;2-7. J Clin Apher. 1997. PMID: 9263113

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page